Return On Equity of OCULAR THERAPEUTIX, INC from 31 Mar 2015 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
OCULAR THERAPEUTIX, INC quarterly and annual Return On Equity in % history and change rate from 31 Mar 2015 to 31 Dec 2025.
  • OCULAR THERAPEUTIX, INC Return On Equity for the quarter ending 31 Dec 2025 was -72%, a 35% decline year-over-year.
  • OCULAR THERAPEUTIX, INC annual Return On Equity for 2025 was -72%, a 35% decline from 2024.
  • OCULAR THERAPEUTIX, INC annual Return On Equity for 2024 was -53%, a 82% increase from 2023.
  • OCULAR THERAPEUTIX, INC annual Return On Equity for 2023 was -289%, a 131% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

OCULAR THERAPEUTIX, INC Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -72% -18% -35% 01 Oct 2025 31 Dec 2025
Q3 2025 -87% -30% -54% 01 Jul 2025 30 Sep 2025
Q2 2025 -70% -7.4% -12% 01 Apr 2025 30 Jun 2025
Q1 2025 -59% +32% +35% 01 Jan 2025 31 Mar 2025
Q4 2024 -53% +236% +82% 01 Oct 2024 31 Dec 2024
Q3 2024 -57% +422% +88% 01 Jul 2024 30 Sep 2024
Q2 2024 -63% +322% +84% 01 Apr 2024 30 Jun 2024
Q1 2024 -90% +136% +60% 01 Jan 2024 31 Mar 2024
Q4 2023 -289% -164% -131% 01 Oct 2023 31 Dec 2023
Q3 2023 -479% -394% -464% 01 Jul 2023 30 Sep 2023
Q2 2023 -384% -344% -849% 01 Apr 2023 30 Jun 2023
Q1 2023 -226% -200% -753% 01 Jan 2023 31 Mar 2023
Q4 2022 -125% -117% -1517% 01 Oct 2022 31 Dec 2022
Q3 2022 -85% +23% +21% 01 Jul 2022 30 Sep 2022
Q2 2022 -41% +134% +77% 01 Apr 2022 30 Jun 2022
Q1 2022 -26% +300% +92% 01 Jan 2022 31 Mar 2022
Q4 2021 -7.7% +926% +99% 01 Oct 2021 31 Dec 2021
Q3 2021 -108% -3047% -104% 01 Jul 2021 30 Sep 2021
Q2 2021 -175% +17291% +99% 01 Apr 2021 30 Jun 2021
Q1 2021 -326% +6563% +95% 01 Jan 2021 31 Mar 2021
Q4 2020 -934% -103% -12% 01 Oct 2020 31 Dec 2020
Q3 2020 2939% +3323% 01 Jul 2020 30 Sep 2020
Q2 2020 -17466% -17209% -6705% 01 Apr 2020 30 Jun 2020
Q1 2020 -6889% -6723% -4054% 01 Jan 2020 31 Mar 2020
Q4 2019 -831% -695% -511% 01 Oct 2019 31 Dec 2019
Q3 2019 -384% -250% -187% 01 Jul 2019 30 Sep 2019
Q2 2019 -257% -113% -79% 01 Apr 2019 30 Jun 2019
Q1 2019 -166% -12% -8% 01 Jan 2019 31 Mar 2019
Q4 2018 -136% +9.6% +6.6% 01 Oct 2018 31 Dec 2018
Q3 2018 -134% -7.4% -5.9% 01 Jul 2018 30 Sep 2018
Q2 2018 -143% -42% -42% 01 Apr 2018 30 Jun 2018
Q1 2018 -154% -73% -91% 01 Jan 2018 31 Mar 2018
Q4 2017 -146% -78% -116% 01 Oct 2017 31 Dec 2017
Q3 2017 -126% -70% -125% 01 Jul 2017 30 Sep 2017
Q2 2017 -101% -49% -93% 01 Apr 2017 30 Jun 2017
Q1 2017 -80% -35% -76% 01 Jan 2017 31 Mar 2017
Q4 2016 -68% -22% -48% 01 Oct 2016 31 Dec 2016
Q3 2016 -56% -9.7% -21% 01 Jul 2016 30 Sep 2016
Q2 2016 -52% -6.4% -14% 01 Apr 2016 30 Jun 2016
Q1 2016 -46% +64% +58% 01 Jan 2016 31 Mar 2016
Q4 2015 -45% 01 Oct 2015 31 Dec 2015
Q3 2015 -47% 01 Jul 2015 30 Sep 2015
Q2 2015 -46% 01 Apr 2015 30 Jun 2015
Q1 2015 -109% 01 Jan 2015 31 Mar 2015

OCULAR THERAPEUTIX, INC Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -72% -18% -35% 01 Jan 2025 31 Dec 2025
2024 -53% +236% +82% 01 Jan 2024 31 Dec 2024
2023 -289% -164% -131% 01 Jan 2023 31 Dec 2023
2022 -125% -117% -1517% 01 Jan 2022 31 Dec 2022
2021 -7.7% +926% +99% 01 Jan 2021 31 Dec 2021
2020 -934% -103% -12% 01 Jan 2020 31 Dec 2020
2019 -831% -695% -511% 01 Jan 2019 31 Dec 2019
2018 -136% +9.6% +6.6% 01 Jan 2018 31 Dec 2018
2017 -146% -78% -116% 01 Jan 2017 31 Dec 2017
2016 -68% -22% -48% 01 Jan 2016 31 Dec 2016
2015 -45% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.